Skip to main content

Sleep Apnea Increases Risk for Dementia in Older Adults Over Time

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 5, 2024.

via HealthDay

TUESDAY, Nov. 5, 2024 -- Obstructive sleep apnea (OSA) contributes to dementia risk in older adults, particularly women, according to a study published online Oct. 22 in Sleep Advances.

Tiffany J. Braley, M.D., from the University of Michigan in Ann Arbor, and colleagues evaluated sex-specific associations between known or suspected OSA and dementia risk over 10 years. The analysis included 18,815 women and men (aged 50 years and older) participating in the Health and Retirement Study.

The researchers found that known/suspected OSA was associated with a higher cumulative incidence of dementia across ages 60 to 84 years for women and men. Compared with adults without known/suspected OSA, by age 80 years, the cumulative incidence of dementia was 4.7 percent higher for women with known/suspected OSA versus 2.5 percent for men with known/suspected OSA. When adjusting for age-specific OSA and cumulative incidence of dementia, results remained significant but were attenuated for both women and men.

"Our findings offer new insight into the role of a treatable sleep disorder on long-term cognitive health at the population level for both women and men," Braley said in a statement. "These potential harms caused by sleep apnea, many of which threaten cognitive performance and decline, highlight the importance of early diagnosis and treatment."

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity

TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...

Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM

MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...

Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI

FRIDAY, July 11, 2025 -- For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild cognitive impairment (MCI)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.